These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4161102)

  • 1. Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis.
    Fullmer HM; Gibson WA; Lazarus G; Stam AC
    Lancet; 1966 May; 1(7445):1007-9. PubMed ID: 4161102
    [No Abstract]   [Full Text] [Related]  

  • 2. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis.
    Ono S; Yamauchi M
    Ann Neurol; 1992 Mar; 31(3):305-10. PubMed ID: 1637138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: unusually low content of collagen in skin.
    Ono S; Mechanic GL; Yamauchi M
    J Neurol Sci; 1990 Dec; 100(1-2):234-7. PubMed ID: 2089137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose metabolism in five neuromuscular disorders.
    Collis WJ; Engel WK
    Neurology; 1968 Sep; 18(9):915-25. PubMed ID: 4301063
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of glucose, insulin, and lipid metabolism in amyotrophic lateral sclerosis and other neuromuscular disorders.
    Mueller PS; Quick DT
    J Lab Clin Med; 1970 Aug; 76(2):190-201. PubMed ID: 5434000
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased expression of laminin 1 in the skin of amyotrophic lateral sclerosis.
    Ono S; Imai T; Shimizu N; Nagao K
    Eur Neurol; 2000; 43(4):215-20. PubMed ID: 10828651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenase activity in skin fibroblasts of patients with amyotrophic lateral sclerosis.
    Beach RL; Rao JS; Festoff BW; Reyes ET; Yanagihara R; Gajdusek DC
    J Neurol Sci; 1986 Jan; 72(1):49-60. PubMed ID: 3005515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyotrophic lateral sclerosis: increased solubility of skin collagen.
    Ono S; Yamauchi M
    Neurology; 1992 Aug; 42(8):1535-9. PubMed ID: 1641149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-compaction delineates amyotrophic lateral sclerosis from metabolic myopathy.
    Finsterer J; Stöllberger C; Güler N
    Int J Cardiol; 2014 Sep; 176(1):277-9. PubMed ID: 25049005
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuromuscular junction macromolecules in the pathogenesis of amyotrophic leteral sclerosis.
    Festoff BW
    Med Hypotheses; 1980 Feb; 6(2):121-31. PubMed ID: 6248744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical aspects of the pathogenesis of amyotrophic lateral sclerosis].
    Zavalishin IA; Khokhlov AP; Larskiĭ EG; Seĭfulla RD; Roĭkhel' VM
    Vestn Akad Med Nauk SSSR; 1988; (12):49-56. PubMed ID: 3071018
    [No Abstract]   [Full Text] [Related]  

  • 12. [Muscular weakness and creatinine excretion (author's transl)].
    Weisner B; Frerk C; Bernhardt W
    Nervenarzt; 1979 Sep; 50(9):582-6. PubMed ID: 537668
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.
    Gil-Bea FJ; Aldanondo G; Lasa-Fernández H; López de Munain A; Vallejo-Illarramendi A
    Expert Rev Mol Med; 2017 Jun; 19():e7. PubMed ID: 28597807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis.
    Suzuki M; Watanabe T; Mikami H; Nomura M; Yamazaki T; Irie T; Ishikawa H; Yasui K; Ono S
    J Neurol Sci; 2009 Oct; 285(1-2):125-9. PubMed ID: 19592043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.
    Field NC; Caller TA; Stommel EW
    Med Hypotheses; 2011 Oct; 77(4):565-7. PubMed ID: 21745715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On pseudoforms of amyotrophic lateral sclerosis of circulatory origin].
    Ramelli E; Mapelli G
    Arcisp S Anna Ferrara; 1970; 23(4):273-90. PubMed ID: 5523487
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
    Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
    Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.
    Conti A; Riva N; Pesca M; Iannaccone S; Cannistraci CV; Corbo M; Previtali SC; Quattrini A; Alessio M
    Biochim Biophys Acta; 2014 Jan; 1842(1):99-106. PubMed ID: 24184715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
    Ziegler MG; Brooks BR; Lake CR; Wood JH; Enna SJ
    Neurology; 1980 Jan; 30(1):98-101. PubMed ID: 7188643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELECTROMYOGRAM IN MUSCULAR DYSTROPHY. WITH PARTICULAR REFERENCE TO DIFFERENTIAL DIAGNOSIS BETWEEN THIS DISEASE AND OTHER NEUROMUSCULAR DISORDERS.
    MARINACCI AA
    Bull Los Angel Neuro Soc; 1964 Mar; 29():7-16. PubMed ID: 14129457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.